Monday, May 28, 2018 9:15:24 AM
The report did not explain the significant value of MCL’s unique seed bank, being one of the only recognised local lawful sources of cannabis genetics in Australia, and with over 25 unique varieties of cannabis that Andrew has been cultivating in his research over the past two decades.
Under international law and the UN Drug Conventions, having a lawful source of cannabis genetics enables the legal development of product in Australia and internationally, which nearly all other companies currently simply do not have that legal ability in their own right.
MCL owning its own genetics also means that when, during the current ongoing research, the genetics of any of these varieties are found to have particular unique medical benefits, then the value of owning these strains will become extremely significant.
Recent CGB News
- Important Notice of Dividend Announcement to shareholder of Xtrackers II • UK Regulatory • 07/31/2023 08:00:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM